SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Medicare Part D Update — Lessons Learned and Unfinished Business
9 references·0 citing·44 second hop
Medicare Part D Update — Lessons Learned and Unfinished Business (2009)Medicare Part D Update — Lessons Learned …The Effects Of The Coverage Gap On Drug Spending: A Closer Look At Medicare Part D (2009)The Effects Of The Coverage G…The Effect Of Medicare Part D Coverage On Drug Use And Cost Sharing Among Seniors Without Prior Drug Benefits (2009)The Effect Of Medicare Part D…The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and Expenditures (2008)The Effect of the Medicare Pa…The Effect of Medicare Part D on Pharmaceutical Prices and Utilization (2008)The Effect of Medicare Part D…Should Drug Prices Be Negotiated Under Part D Of Medicare? And If So, How? (2008)Should Drug Prices Be Negotia…Prescription Drug Spending Trends In The United States: Looking Beyond The Turning Point (2008)Prescription Drug Spending Tr…The Impact Of Medicare Part D On Prescription Drug Use By The Elderly (2007)The Impact Of Medicare Part D…Medicare Prescription Drug Benefit Progress Report: Findings From A 2006 National Survey Of Seniors (2007)Medicare Prescription Drug Be…Who Failed To Enroll In Medicare Part D, And Why? Early Results (2006)Who Failed To Enroll In Medic…Does Public Insurance Crowd out Private Insurance? (1996)The Effect of Medicare Part D on Pharmaceutical Prices and Utilization (2010)Economics of the Pharmaceutical Industry (2018)Mail and Telephone Surveys: The Total Design Method. (1979)Mail and Telephone Surveys: The Total Design Method. (1982)Prescription Drug Coverage And Seniors: Findings From A 2003 National Survey (2005)Medicare Beneficiaries' Knowledge of Part D Prescription Drug Program Benefits and Responses to Drug Costs (2008)How Much Choice Is Too Much? The Case of the Medicare Prescription Drug Benefit (2009)Understanding Nonresponse to the 2007 Medicare CAHPS Survey (2011)Payment Restrictions for Prescription Drugs under Medicaid (1987)Self-restriction of medications due to cost in seniors without prescription coverage (2001)Unintended Consequences of Caps on Medicare Drug Benefits (2006)Cost-sharing: effects on spending and outcomes. (2010)Implementation of Medicare Part D and Nondrug Medical Spending for Elderly Adults With Limited Prior Drug Coverage (2011)The Impact of Medicare Part D on Hospitalization Rates (2011)Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. (1992)The logged dependent variable, heteroscedasticity, and the retransformation problem (1998)Use of Census-based Aggregate Variables to Proxy for Socioeconomic Group: Evidence from National Samples (1998)Hospitalizations and Deaths Among Adults With Cardiovascular Disease Who Underuse Medications Because of Cost (2010)The Response of Drug Expenditure to Nonlinear Contract Design: Evidence from Medicare Part D * (2015)Health Care Financing Review (1980)Pharmacy Benefits and the Use of Drugs by the Chronically Ill (2004)Risk adjustment of Medicare capitation payments using the CMS-HCC model. (2004)Regulation of Insurance with Adverse Selection and Switching Costs: Evidence from Medicare Part D (2016)Influencers of generic drug utilization: A systematic review (2017)The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules (1996)Prescription Drug Prices: Why Do Some Pay More Than Others Do? (2001)The Economic Value of Medical Research (2003)The Impact of Medicare Part D on Out-of-Pocket Costs for Prescription Drugs, Medication Utilization, Health Resource Utilization, and Preference-Based Health Utility (2011)A Transparent and Consistent Approach to Assess US Outpatient Drug Costs for Use in Cost-Effectiveness Analyses (2017)Free Markets and Fettered Consumers (2006)Take-up of Medicare Part D: Results From the Health and Retirement Study (2009)Sexual Behaviors, Relationships, and Perceived Health Status Among Adult Women in the United States: Results from a National Probability Sample (2010)Evolving Choice Inconsistencies in Choice of Prescription Drug Insurance (2016)Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)The price of innovation: new estimates of drug development costs (2003)UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination (2020)Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry (2004)Prescription drug cost sharing: associations with medication and medical utilization and spending and health. (2007)Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers (2007)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists (2013)Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry (2016)
this work references cited by second hop

References

  • 2007The Impact Of Medicare Part D On Prescription Drug Use By The Elderly223 cited
  • 2008The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and Expenditures202 cited
  • 2007Medicare Prescription Drug Benefit Progress Report: Findings From A 2006 National Survey Of Seniors155 cited
  • 2008Prescription Drug Spending Trends In The United States: Looking Beyond The Turning Point142 cited
  • 2006Who Failed To Enroll In Medicare Part D, And Why? Early Results132 cited
  • 2009The Effect Of Medicare Part D Coverage On Drug Use And Cost Sharing Among Seniors Without Prior Drug Benefits98 cited
  • 2009The Effects Of The Coverage Gap On Drug Spending: A Closer Look At Medicare Part D98 cited
  • 2008Should Drug Prices Be Negotiated Under Part D Of Medicare? And If So, How?70 cited
  • 2008The Effect of Medicare Part D on Pharmaceutical Prices and Utilization55 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work